Pivotal study to evaluate AuroLase therapy for prostate tissue ablation Nanospectra Biosciences, Inc. recently announced the start of a pivotal study to determine the efficacy of using magnetic resonance imaging/ultrasound fusion imaging technology to direct focal...
Could photothermal therapy become the ‘gold standard’ of cancer treatment? The first clinical trial of photothermal therapy, a promising cancer treatment, has demonstrated successful results. While photothermal therapy has been extensively tested in preclinical...
Focal Therapy, AuroLase, Shows Good Safety and Potential Effectiveness in Pilot Clinical Trial Nanospectra Biosciences’ AuroLase Therapy, a focal therapy for prostate cancer that uses gold-silica nanoparticles, showed a good safety profile and evidence of...
By Liz Hollis Men with low-to-intermediate grade tumors face a tough choice, with treatment choices that have adverse effects. Although laser ablation has offered an avenue of hope, the U.S. FDA has advised of the potential for tissue overheating in connection with...
When imaging of the prostate shows only one small area of cancer, “why can’t you treat just that spot, instead of the whole prostate?” frustrated patients keep asking. This is what a new approach now being tested aims to do, says Ardeshir R....
Recent Comments